{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35639675", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "31"}], "Language": ["eng"], "ELocationID": ["e0269250", "10.1371/journal.pone.0269250"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "17", "Issue": "5", "PubDate": {"Year": "2022"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.", "Pagination": {"StartPage": "e0269250", "MedlinePgn": "e0269250"}, "Abstract": {"AbstractText": ["Due to their common routes of transmission, human immunodeficiency virus (HIV) coinfection with hepatitis B virus (HBV) and/or hepatitis C virus (HCV) has become a major public health problem worldwide, particularly in Africa, where these viruses are endemic. Few systematic reviews report the epidemiological data of HBV and/or HCV coinfection with HIV in Africa, and none provided data on the case fatality rate (CFR) associated with this coinfection. This study was conducted to investigate the prevalence and case fatality rate of HBV and/or HCV infections among people living with human immunodeficiency virus (PLHIV) in Africa.", "We conducted a systematic review of published articles in PubMed, Web of Science, African Journal Online, and African Index Medicus up to January 2022. Manual searches of references from retrieved articles and grey literature were also performed. The meta-analysis was performed using a random-effects model. Sources of heterogeneity were investigated using subgroup analysis, while funnel plots and Egger tests were performed to assess publication bias.", "Of the 4388 articles retrieved from the databases, 314 studies met all the inclusion criteria. The overall HBV case fatality rate estimate was 4.4% (95% CI; 0.7-10.3). The overall seroprevalences of HBV infection, HCV infection, and HBV/HCV coinfection in PLHIV were 10.5% [95% CI = 9.6-11.3], 5.4% [95% CI = 4.6-6.2], and 0.7% [95% CI = 0.3-1.0], respectively. The pooled seroprevalences of current HBsAg, current HBeAg, and acute HBV infection among PLHIV were 10.7% [95% CI = 9.8-11.6], 7.0% [95% CI = 4.7-9.7], and 3.6% [95% CI = 0.0-11.0], respectively. Based on HBV-DNA and HCV-RNA detection, the seroprevalences of HBV and HCV infection in PLHIV were 17.1% [95% CI = 11.5-23.7] and 2.5% [95% CI = 0.9-4.6], respectively. Subgroup analysis showed substantial heterogeneity.", "In Africa, the prevalence of hepatotropic viruses, particularly HBV and HCV, is high in PLHIV, which increases the case fatality rate. African public health programs should emphasize the need to apply and comply with WHO guidelines on viral hepatitis screening and treatment in HIV-coinfected patients.", "PROSPERO, CRD42021237795."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Kenfack-Momo", "ForeName": "Raoul", "Initials": "R"}, {"Identifier": ["0000-0002-5536-080X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}, {"Identifier": [], "Affiliation": "Virology Department, Centre Pasteur of Cameroon, Yaound\u00e9, Cameroon."}], "LastName": "Kenmoe", "ForeName": "Sebastien", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Research on Health and Priority Pathologies, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Takuissu", "ForeName": "Guy Roussel", "Initials": "GR"}, {"Identifier": ["0000-0002-4057-889X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Research on Health and Priority Pathologies, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Ebogo-Belobo", "ForeName": "Jean Thierry", "Initials": "JT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Epidemiological Surveillance, Evaluation and Research Unit, National AIDS Control Committee, Douala, Cameroon."}], "LastName": "Kengne-Nd\u00e9", "ForeName": "Cyprien", "Initials": "C"}, {"Identifier": ["0000-0002-9496-0445"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Mbaga", "ForeName": "Donatien Serge", "Initials": "DS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Scientific Direction, Centre Pasteur of Cameroon, Yaounde, Cameroon."}], "LastName": "Tchatchouang", "ForeName": "Serges", "Initials": "S"}, {"Identifier": ["0000-0002-0990-4087"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Research on Health and Priority Pathologies, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Oyono", "ForeName": "Martin Gael", "Initials": "MG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Kenfack-Zanguim", "ForeName": "Josiane", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, University of Dschang, Dschang, Cameroon."}], "LastName": "Lontuo Fogang", "ForeName": "Robertine", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Mbongue Mikangue", "ForeName": "Chris Andre", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Zeuko'o Menkem", "ForeName": "Elisabeth", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Ndzie Ondigui", "ForeName": "Juliette Laure", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Research on Health and Priority Pathologies, Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon."}], "LastName": "Kame-Ngasse", "ForeName": "Ginette Irma", "Initials": "GI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Magoudjou-Pekam", "ForeName": "Jeannette Nina", "Initials": "JN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Taya-Fokou", "ForeName": "Jean Bosco", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Bowo-Ngandji", "ForeName": "Arnol", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}], "LastName": "Nkie Esemu", "ForeName": "Seraphine", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Kamdem Thiomo", "ForeName": "Diane", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, The University of Yaounde I, Yaounde, Cameroon."}], "LastName": "Moundipa Fewou", "ForeName": "Paul", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon."}], "LastName": "Ndip", "ForeName": "Lucy", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology Department, Centre Pasteur of Cameroon, Yaound\u00e9, Cameroon."}], "LastName": "Njouom", "ForeName": "Richard", "Initials": "R"}], "GrantList": [{"GrantID": "EDCTP_TMA2019PF-2705", "Acronym": "EDCTP_", "Agency": "European &#x26; Developing Countries Clinical Trials Partnership", "Country": "Netherlands"}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Systematic Review", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "MeshHeadingList": [{"QualifierName": ["epidemiology"], "DescriptorName": "Africa"}, {"QualifierName": ["complications", "epidemiology"], "DescriptorName": "Coinfection"}, {"QualifierName": [], "DescriptorName": "HIV"}, {"QualifierName": ["complications", "epidemiology"], "DescriptorName": "HIV Infections"}, {"QualifierName": [], "DescriptorName": "Hepacivirus"}, {"QualifierName": ["complications", "epidemiology"], "DescriptorName": "Hepatitis B"}, {"QualifierName": [], "DescriptorName": "Hepatitis B virus"}, {"QualifierName": ["complications", "epidemiology"], "DescriptorName": "Hepatitis C"}, {"QualifierName": [], "DescriptorName": "Humans"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. The lancet HIV. 2019;6(12):e831\u2013e59. Epub 2019/08/24. doi: 10.1016/S2352-3018(19)30196-1 ; PubMed Central PMCID: PMC6934077.", "ArticleIdList": ["10.1016/S2352-3018(19)30196-1", "PMC6934077", "31439534"]}, {"Citation": "UNAIDS. Global HIV & AIDS statistics\u2014Fact sheet. 2022."}, {"Citation": "Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44(1 Suppl):S6\u20139. Epub 2005/12/15. doi: 10.1016/j.jhep.2005.11.004 .", "ArticleIdList": ["10.1016/j.jhep.2005.11.004", "16352363"]}, {"Citation": "Leumi S, Bigna JJ, Amougou MA, Ngouo A, Nyaga UF, Noubiap JJ. Global Burden of Hepatitis B Infection in People Living With Human Immunodeficiency Virus: A Systematic Review and Meta-analysis. Clin Infect Dis. 2020;71(11):2799\u2013806. Epub 2019/12/10. doi: 10.1093/cid/ciz1170 .", "ArticleIdList": ["10.1093/cid/ciz1170", "31813969"]}, {"Citation": "Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al.. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. The Lancet Infectious diseases. 2016;16(7):797\u2013808. Epub 2016/02/29. doi: 10.1016/S1473-3099(15)00485-5 .", "ArticleIdList": ["10.1016/S1473-3099(15)00485-5", "26922272"]}, {"Citation": "Acharya C, Dharel N, Sterling RK. Chronic liver disease in the human immunodeficiency virus patient. Clinics in liver disease. 2015;19(1):1\u201322. Epub 2014/12/03. doi: 10.1016/j.cld.2014.09.001 .", "ArticleIdList": ["10.1016/j.cld.2014.09.001", "25454294"]}, {"Citation": "Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017;28(7):636\u201350. Epub 2016/02/13. doi: 10.1177/0956462416632428 .", "ArticleIdList": ["10.1177/0956462416632428", "26868158"]}, {"Citation": "WHO. Global hepatitis report, 2017. 2017."}, {"Citation": "Rockstroh JK. Influence of viral hepatitis on HIV infection. J Hepatol. 2006;44(1 Suppl):S25\u20137. Epub 2005/12/13. doi: 10.1016/j.jhep.2005.11.007 .", "ArticleIdList": ["10.1016/j.jhep.2005.11.007", "16338020"]}, {"Citation": "Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(5 Suppl):S138\u201345. Epub 2009/04/29. doi: 10.1002/hep.22883 .", "ArticleIdList": ["10.1002/hep.22883", "19399813"]}, {"Citation": "Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, Chaisson RE, et al.. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis. 2008;47(11):1479\u201385. Epub 2008/10/22. doi: 10.1086/593104 ; PubMed Central PMCID: PMC2670447.", "ArticleIdList": ["10.1086/593104", "PMC2670447", "18937580"]}, {"Citation": "Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al.. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356(9244):1800\u20135. Epub 2000/12/16. doi: 10.1016/s0140-6736(00)03232-3 .", "ArticleIdList": ["10.1016/s0140-6736(00)03232-3", "11117912"]}, {"Citation": "Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ. HIV-HBV coinfection\u2014a global challenge. The New England journal of medicine. 2012;366(19):1749\u201352. Epub 2012/05/11. doi: 10.1056/NEJMp1201796 ; PubMed Central PMCID: PMC4453872.", "ArticleIdList": ["10.1056/NEJMp1201796", "PMC4453872", "22571198"]}, {"Citation": "McGovern BH. The epidemiology, natural history and prevention of hepatitis B: implications of HIV coinfection. Antivir Ther. 2007;12 Suppl 3:H3\u201313. Epub 2008/02/21. .", "ArticleIdList": ["18284178"]}, {"Citation": "Thio CL, Seaberg EC, Skolasky R Jr., Phair J, Visscher B, Mu\u00f1oz A, et al.. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360(9349):1921\u20136. Epub 2002/12/21. doi: 10.1016/s0140-6736(02)11913-1 .", "ArticleIdList": ["10.1016/s0140-6736(02)11913-1", "12493258"]}, {"Citation": "Hach\u00e9 C, Villeneuve JP. Lamivudine treatment in patients with chronic hepatitis B and cirrhosis. Expert opinion on pharmacotherapy. 2006;7(13):1835\u201343. Epub 2006/08/24. doi: 10.1517/14656566.7.13.1835 .", "ArticleIdList": ["10.1517/14656566.7.13.1835", "16925509"]}, {"Citation": "Benhamou Y, Bochet M, Thibault V, Di Martino V, Caumes E, Bricaire F, et al.. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology. 1999;30(5):1302\u20136. Epub 1999/10/26. doi: 10.1002/hep.510300525 .", "ArticleIdList": ["10.1002/hep.510300525", "10534354"]}, {"Citation": "Ndow G, Gore ML, Shimakawa Y, Suso P, Jatta A, Tamba S, et al.. Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes. PLoS One. 2017;12(6):e0179025. rayyan-131263203. doi: 10.1371/journal.pone.0179025", "ArticleIdList": ["10.1371/journal.pone.0179025", "PMC5470698", "28614401"]}, {"Citation": "Sun HY, Lee HC, Liu CE, Yang CL, Su SC, Ko WC, et al.. Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunity. Journal of Viral Hepatitis. 2010;17(8):578\u201387. rayyan-131262922. doi: 10.1111/j.1365-2893.2009.01212.x", "ArticleIdList": ["10.1111/j.1365-2893.2009.01212.x", "19818002"]}, {"Citation": "Azevedo TC, Zwahlen M, Rauch A, Egger M, Wandeler G. Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in Africa. J Int AIDS Soc. 2016;19(1):20711. Epub 2016/06/14. doi: 10.7448/IAS.19.1.20711 ; PubMed Central PMCID: PMC4904089.", "ArticleIdList": ["10.7448/IAS.19.1.20711", "PMC4904089", "27293220"]}, {"Citation": "Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14(12):e1024\u201331. Epub 2010/09/28. doi: 10.1016/j.ijid.2010.06.013 .", "ArticleIdList": ["10.1016/j.ijid.2010.06.013", "20870439"]}, {"Citation": "Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Infectious diseases. 2015;15(7):819\u201324. Epub 2015/05/10. doi: 10.1016/S1473-3099(15)00006-7 .", "ArticleIdList": ["10.1016/S1473-3099(15)00006-7", "25957078"]}, {"Citation": "Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al.. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934\u20139. doi: 10.1016/j.jclinepi.2011.11.014 .", "ArticleIdList": ["10.1016/j.jclinepi.2011.11.014", "22742910"]}, {"Citation": "Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to Meta\u2010Analysis. 1 ed: John Wiley & Sons, Ltd; 2009 2009."}, {"Citation": "Schwarzer G. meta: An R Package for Meta-Analysis. 2007;7:7."}, {"Citation": "Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. doi: 10.1136/bmj.327.7414.557", "ArticleIdList": ["10.1136/bmj.327.7414.557", "PMC192859", "12958120"]}, {"Citation": "Introduction to meta-analysis. Borenstein M, editor. Chichester, U.K: John Wiley & Sons; 2009 2009. 421 p."}, {"Citation": "Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. doi: 10.1136/bmj.315.7109.629", "ArticleIdList": ["10.1136/bmj.315.7109.629", "PMC2127453", "9310563"]}, {"Citation": "Chen TY, Ding EL, Seage Iii GR, Kim AY. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis. 2009;49(10):1605\u201315. Epub 2009/10/22. doi: 10.1086/644771 ; PubMed Central PMCID: PMC2805261.", "ArticleIdList": ["10.1086/644771", "PMC2805261", "19842982"]}, {"Citation": "Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, et al.. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis. 2009;48(12):1763\u201371. Epub 2009/05/14. doi: 10.1086/599110 .", "ArticleIdList": ["10.1086/599110", "19435436"]}, {"Citation": "Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, et al.. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology. 2000;119(1):172\u201380. Epub 2000/07/13. doi: 10.1053/gast.2000.8559 .", "ArticleIdList": ["10.1053/gast.2000.8559", "10889166"]}, {"Citation": "Lok AS, Hussain M, Cursano C, Margotti M, Gramenzi A, Grazi GL, et al.. Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy. Hepatology. 2000;32(5):1145\u201353. Epub 2000/10/26. doi: 10.1053/jhep.2000.19622 .", "ArticleIdList": ["10.1053/jhep.2000.19622", "11050068"]}, {"Citation": "Peters DH, Garg A, Bloom G, Walker DG, Brieger WR, Rahman MH. Poverty and access to health care in developing countries. Annals of the New York Academy of Sciences. 2008;1136:161\u201371. Epub 2007/10/24. doi: 10.1196/annals.1425.011 .", "ArticleIdList": ["10.1196/annals.1425.011", "17954679"]}, {"Citation": "Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis. 2014;59(6):765\u201373. Epub 2014/06/15. doi: 10.1093/cid/ciu447 ; PubMed Central PMCID: PMC4144266.", "ArticleIdList": ["10.1093/cid/ciu447", "PMC4144266", "24928290"]}, {"Citation": "Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J. 2013;14:44. Epub 2013/04/06. doi: 10.11604/pamj.2013.14.44.2199 ; PubMed Central PMCID: PMC3612901.", "ArticleIdList": ["10.11604/pamj.2013.14.44.2199", "PMC3612901", "23560127"]}, {"Citation": "Kaplan DE. Hepatitis C Virus. Annals of internal medicine. 2020;173(5):Itc33\u2013itc48. Epub 2020/09/01. doi: 10.7326/AITC202009010 .", "ArticleIdList": ["10.7326/AITC202009010", "32866406"]}, {"Citation": "Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al.. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733\u201345. Epub 2008/09/27. doi: 10.1016/S0140-6736(08)61311-2 .", "ArticleIdList": ["10.1016/S0140-6736(08)61311-2", "18817968"]}, {"Citation": "Grebely J, Larney S, Peacock A, Colledge S, Leung J, Hickman M, et al.. Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction (Abingdon, England). 2019;114(1):150\u201366. Epub 2018/07/24. doi: 10.1111/add.14393 ; PubMed Central PMCID: PMC6657799.", "ArticleIdList": ["10.1111/add.14393", "PMC6657799", "30035835"]}, {"Citation": "J\u00fcrgens R, Csete J, Amon JJ, Baral S, Beyrer C. People who use drugs, HIV, and human rights. Lancet. 2010;376(9739):475\u201385. Epub 2010/07/24. doi: 10.1016/S0140-6736(10)60830-6 .", "ArticleIdList": ["10.1016/S0140-6736(10)60830-6", "20650514"]}, {"Citation": "Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al.. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. The Lancet Global health. 2017;5(12):e1208\u2013e20. Epub 2017/10/28. doi: 10.1016/S2214-109X(17)30373-X ; PubMed Central PMCID: PMC5683737.", "ArticleIdList": ["10.1016/S2214-109X(17)30373-X", "PMC5683737", "29074410"]}, {"Citation": "Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al.. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. The Lancet Global health. 2017;5(12):e1192\u2013e207. Epub 2017/10/28. doi: 10.1016/S2214-109X(17)30375-3 ; PubMed Central PMCID: PMC5683738.", "ArticleIdList": ["10.1016/S2214-109X(17)30375-3", "PMC5683738", "29074409"]}, {"Citation": "Raguin G, Lepretre A, Ba I, Ndoye I, Toufik A, Brucker G, et al.. Drug use and HIV in West Africa: a neglected epidemic. Tropical medicine & international health: TM & IH. 2011;16(9):1131\u20133. Epub 2011/06/16. doi: 10.1111/j.1365-3156.2011.02806.x .", "ArticleIdList": ["10.1111/j.1365-3156.2011.02806.x", "21672093"]}, {"Citation": "Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis. 2012;54(8):1167\u201378. Epub 2012/02/01. doi: 10.1093/cid/cir991 ; PubMed Central PMCID: PMC4613802.", "ArticleIdList": ["10.1093/cid/cir991", "PMC4613802", "22291098"]}, {"Citation": "Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis. 2013;13:288. Epub 2013/06/27. doi: 10.1186/1471-2334-13-288 ; PubMed Central PMCID: PMC3702438.", "ArticleIdList": ["10.1186/1471-2334-13-288", "PMC3702438", "23799878"]}, {"Citation": "Candotti D, Sauvage V, Cappy P, Boullahi MA, Bizimana P, Mbensa GO, et al.. High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply. Transfusion. 2020;60(1):106\u201316. Epub 2019/11/30. doi: 10.1111/trf.15593 .", "ArticleIdList": ["10.1111/trf.15593", "31777096"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "19"}, {"Year": "2022", "Month": "5", "Day": "17"}, {"Year": "2022", "Month": "5", "Day": "31", "Hour": "16", "Minute": "9"}, {"Year": "2022", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["35639675", "PMC9154112", "10.1371/journal.pone.0269250", "PONE-D-22-08184"]}}], "PubmedBookArticle": []}